1036 related articles for article (PubMed ID: 26709942)
1. Efficacy of four commercially available multivalent modified-live virus vaccines against clinical disease, viremia, and viral shedding in early-weaned beef calves exposed simultaneously to cattle persistently infected with bovine viral diarrhea virus and cattle acutely infected with bovine herpesvirus 1.
Chamorro MF; Walz PH; Passler T; Palomares R; Newcomer BW; Riddell KP; Gard J; Zhang Y; Galik P
Am J Vet Res; 2016 Jan; 77(1):88-97. PubMed ID: 26709942
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of shedding of bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 after vaccination of calves with a multivalent modified-live virus vaccine.
Kleiboeker SB; Lee SM; Jones CA; Estes DM
J Am Vet Med Assoc; 2003 May; 222(10):1399-403. PubMed ID: 12762386
[TBL] [Abstract][Full Text] [Related]
3. Protective effects against abortion and fetal infection following exposure to bovine viral diarrhea virus and bovine herpesvirus 1 during pregnancy in beef heifers that received two doses of a multivalent modified-live virus vaccine prior to breeding.
Givens MD; Marley MS; Jones CA; Ensley DT; Galik PK; Zhang Y; Riddell KP; Joiner KS; Brodersen BW; Rodning SP
J Am Vet Med Assoc; 2012 Aug; 241(4):484-95. PubMed ID: 22852575
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of multivalent, modified- live virus (MLV) vaccines administered to early weaned beef calves subsequently challenged with virulent Bovine viral diarrhea virus type 2.
Chamorro MF; Walz PH; Passler T; van Santen E; Gard J; Rodning SP; Riddell KP; Galik PK; Zhang Y
BMC Vet Res; 2015 Feb; 11():29. PubMed ID: 25880998
[TBL] [Abstract][Full Text] [Related]
5. Cell-mediated and humoral immune responses to bovine herpesvirus type 1 and bovine viral diarrhea virus in calves following administration of a killed-virus vaccine and bovine herpesvirus type 1 challenge.
Van Anne TR; Rinehart CL; Buterbaugh RE; Bauer MJ; Young AJ; Blaha ML; Klein AL; Chase CCL
Am J Vet Res; 2018 Nov; 79(11):1166-1178. PubMed ID: 30372148
[TBL] [Abstract][Full Text] [Related]
6. Effects of injectable trace minerals on humoral and cell-mediated immune responses to Bovine viral diarrhea virus, Bovine herpes virus 1 and Bovine respiratory syncytial virus following administration of a modified-live virus vaccine in dairy calves.
Palomares RA; Hurley DJ; Bittar JH; Saliki JT; Woolums AR; Moliere F; Havenga LJ; Norton NA; Clifton SJ; Sigmund AB; Barber CE; Berger ML; Clark MJ; Fratto MA
Vet Immunol Immunopathol; 2016 Oct; 178():88-98. PubMed ID: 27496747
[TBL] [Abstract][Full Text] [Related]
7. One year duration of immunity of the modified live bovine viral diarrhea virus type 1 and type 2 and bovine herpesvirus-1 fractions of Vista® Once SQ vaccine.
Purtle L; Mattick D; Schneider C; Smith L; Xue W; Trigo E
Vaccine; 2016 Mar; 34(13):1582-1588. PubMed ID: 26859238
[TBL] [Abstract][Full Text] [Related]
8. Clinical status and endoscopy of the upper respiratory tract of dairy calves infected with Bovine viral diarrhea virus 2 and Bovine herpes virus 1 after vaccination and trace minerals injection.
Hoyos-Jaramillo A; Palomares RA; Bittar JH; Divers SJ; Chamorro MF; Berghaus R; Kirks SJ; Rush J; Edmondson M; Rodriguez A; Gonzalez-Altamiranda EA
Res Vet Sci; 2022 Dec; 152():582-595. PubMed ID: 36201905
[TBL] [Abstract][Full Text] [Related]
9. Transmission of bovine viral diarrhea virus 1b to susceptible and vaccinated calves by exposure to persistently infected calves.
Fulton RW; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Payton ME; Duff GC; Step DL; Walker DA
Can J Vet Res; 2005 Jul; 69(3):161-9. PubMed ID: 16187545
[TBL] [Abstract][Full Text] [Related]
10. Characterization of protection against systemic infection and disease from experimental bovine viral diarrhea virus type 2 infection by use of a modified-live noncytopathic type 1 vaccine in calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Eskridge KM
Am J Vet Res; 2007 Jul; 68(7):788-96. PubMed ID: 17605616
[TBL] [Abstract][Full Text] [Related]
11. Vaccination of cattle against bovine viral diarrhea virus.
Newcomer BW; Chamorro MF; Walz PH
Vet Microbiol; 2017 Jul; 206():78-83. PubMed ID: 28400145
[TBL] [Abstract][Full Text] [Related]
12. Challenge with Bovine viral diarrhea virus by exposure to persistently infected calves: protection by vaccination and negative results of antigen testing in nonvaccinated acutely infected calves.
Fulton RW; Johnson BJ; Briggs RE; Ridpath JF; Saliki JT; Confer AW; Burge LJ; Step DL; Walker DA; Payton ME
Can J Vet Res; 2006 Apr; 70(2):121-7. PubMed ID: 16639944
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of responses to vaccination of Angus cattle for four viruses that contribute to bovine respiratory disease complex.
Kramer LM; Mayes MS; Fritz-Waters E; Williams JL; Downey ED; Tait RG; Woolums A; Chase C; Reecy JM
J Anim Sci; 2017 Nov; 95(11):4820-4834. PubMed ID: 29293723
[TBL] [Abstract][Full Text] [Related]
14. Comparison of three commercial vaccines for preventing persistent infection with bovine viral diarrhea virus.
Rodning SP; Marley MS; Zhang Y; Eason AB; Nunley CL; Walz PH; Riddell KP; Galik PK; Brodersen BW; Givens MD
Theriogenology; 2010 May; 73(8):1154-63. PubMed ID: 20181385
[TBL] [Abstract][Full Text] [Related]
15. Bovine viral diarrhea virus (BVDV) 1b: predominant BVDV subtype in calves with respiratory disease.
Fulton RW; Ridpath JF; Saliki JT; Briggs RE; Confer AW; Burge LJ; Purdy CW; Loan RW; Duff GC; Payton ME
Can J Vet Res; 2002 Jul; 66(3):181-90. PubMed ID: 12146890
[TBL] [Abstract][Full Text] [Related]
16. [Vaccination of calves with contaminated batches of bovine herpes virus 1 vaccines did not result in infection with bovine virus diarrhea virus].
Antonis AF; van Oirschot JT; van Es M; Bruschke CJ
Tijdschr Diergeneeskd; 2001 Mar; 126(6):208-11. PubMed ID: 11285641
[TBL] [Abstract][Full Text] [Related]
17. Investigation of bovine viral diarrhea virus infections in a range beef cattle herd.
Kelling CL; Stine LC; Rump KK; Parker RE; Kennedy JE; Stone RT; Ross GS
J Am Vet Med Assoc; 1990 Sep; 197(5):589-93. PubMed ID: 2170313
[TBL] [Abstract][Full Text] [Related]
18. Characterization of protection from systemic infection and disease by use of a modified-live noncytopathic bovine viral diarrhea virus type 1 vaccine in experimentally infected calves.
Kelling CL; Hunsaker BD; Steffen DJ; Topliff CL; Abdelmagid OY; Eskridge KM
Am J Vet Res; 2005 Oct; 66(10):1785-91. PubMed ID: 16273912
[TBL] [Abstract][Full Text] [Related]
19. The live attenuated bovine viral diarrhea virus components of a multi-valent vaccine confer protection against fetal infection.
Kovács F; Magyar T; Rinehart C; Elbers K; Schlesinger K; Ohnesorge WC
Vet Microbiol; 2003 Oct; 96(2):117-31. PubMed ID: 14519330
[TBL] [Abstract][Full Text] [Related]
20. Effect of vaccination of pregnant beef heifers on the concentrations of serum IgG and specific antibodies to bovine herpesvirus 1, bovine viral diarrhea virus 1, and bovine viral diarrhea virus 2 in heifers and calves.
Reppert EJ; Chamorro MF; Robinson L; Cernicchiaro N; Wick J; Weaber RL; Haines DM
Can J Vet Res; 2019 Oct; 83(4):313-316. PubMed ID: 31571732
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
